These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


1254 related items for PubMed ID: 22584010

  • 1. Percutaneous cryoablation of solitary sporadic renal cell carcinomas.
    Schmit GD, Thompson RH, Kurup AN, Weisbrod AJ, Carter RE, Callstrom MR, Atwell TD.
    BJU Int; 2012 Dec; 110(11 Pt B):E526-31. PubMed ID: 22584010
    [Abstract] [Full Text] [Related]

  • 2. Percutaneous cryoablation of renal masses: Washington University experience of treating 129 tumours.
    Kim EH, Tanagho YS, Bhayani SB, Saad NE, Benway BM, Figenshau RS.
    BJU Int; 2013 May; 111(6):872-9. PubMed ID: 23145500
    [Abstract] [Full Text] [Related]

  • 3. Percutaneous cryoablation of anterior renal masses: technique, efficacy, and safety.
    Schmit GD, Atwell TD, Leibovich BC, Callstrom MR, Kurup AN, Woodrum DA, Charboneau JW.
    AJR Am J Roentgenol; 2010 Dec; 195(6):1418-22. PubMed ID: 21098204
    [Abstract] [Full Text] [Related]

  • 4. Comparison of percutaneous and laparoscopic cryoablation for the treatment of solid renal masses.
    Hinshaw JL, Shadid AM, Nakada SY, Hedican SP, Winter TC, Lee FT.
    AJR Am J Roentgenol; 2008 Oct; 191(4):1159-68. PubMed ID: 18806159
    [Abstract] [Full Text] [Related]

  • 5. Laparoscopic renal cryoablation using ultrathin 17-gauge cryoprobes: mid-term oncological and functional results.
    Beemster PW, Barwari K, Mamoulakis C, Wijkstra H, de la Rosette JJ, Laguna MP.
    BJU Int; 2011 Aug; 108(4):577-82. PubMed ID: 21044249
    [Abstract] [Full Text] [Related]

  • 6. Safety and efficacy of CT-guided percutaneous cryoablation for renal cell carcinoma.
    Georgiades CS, Hong K, Bizzell C, Geschwind JF, Rodriguez R.
    J Vasc Interv Radiol; 2008 Sep; 19(9):1302-10. PubMed ID: 18725093
    [Abstract] [Full Text] [Related]

  • 7. Percutaneous cryoablation of renal cell carcinoma guided by horizontal open magnetic resonance imaging.
    Miki K, Shimomura T, Yamada H, Kishimoto K, Ohishi Y, Harada J, Egawa S.
    Int J Urol; 2006 Jul; 13(7):880-4. PubMed ID: 16882047
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Percutaneous Cryoablation of Clinical T2 (> 7 cm) Renal Masses: Technical Considerations, Complications, and Short-Term Outcomes.
    Moynagh MR, Schmit GD, Thompson RH, Boorjian SA, Woodrum DA, Curry TB, Atwell TD.
    J Vasc Interv Radiol; 2015 Jun; 26(6):800-6. PubMed ID: 25840835
    [Abstract] [Full Text] [Related]

  • 11. Efficacy and safety of percutaneous cryoablation for stage 1A/B renal cell carcinoma: results of a prospective, single-arm, 5-year study.
    Georgiades CS, Rodriguez R.
    Cardiovasc Intervent Radiol; 2014 Dec; 37(6):1494-9. PubMed ID: 24385225
    [Abstract] [Full Text] [Related]

  • 12. Percutaneous cryoablation of small kidney tumours under magnetic resonance imaging guidance: medium-term follow-up.
    Caviezel A, Terraz S, Schmidlin F, Becker C, Iselin CE.
    Scand J Urol Nephrol; 2008 Dec; 42(5):412-6. PubMed ID: 18609277
    [Abstract] [Full Text] [Related]

  • 13. Percutaneous renal cryoablation after partial nephrectomy: technical feasibility, complications and outcomes.
    Hegg RM, Schmit GD, Boorjian SA, McDonald RJ, Kurup AN, Weisbrod AJ, Callstrom MR, Atwell TD, Thompson RH.
    J Urol; 2013 Apr; 189(4):1243-8. PubMed ID: 23123377
    [Abstract] [Full Text] [Related]

  • 14. Partial nephrectomy for renal masses ≥ 7 cm: technical, oncological and functional outcomes.
    Long CJ, Canter DJ, Kutikov A, Li T, Simhan J, Smaldone M, Teper E, Viterbo R, Boorjian SA, Chen DY, Greenberg RE, Uzzo RG.
    BJU Int; 2012 May; 109(10):1450-6. PubMed ID: 22221502
    [Abstract] [Full Text] [Related]

  • 15. Percutaneous ablation of renal masses measuring 3.0 cm and smaller: comparative local control and complications after radiofrequency ablation and cryoablation.
    Atwell TD, Schmit GD, Boorjian SA, Mandrekar J, Kurup AN, Weisbrod AJ, Chow GK, Leibovich BC, Callstrom MR, Patterson DE, Lohse CM, Thompson RH.
    AJR Am J Roentgenol; 2013 Feb; 200(2):461-6. PubMed ID: 23345372
    [Abstract] [Full Text] [Related]

  • 16. Percutaneous cryoablation of renal masses >or=3 cm: efficacy and safety in treatment of 108 patients.
    Schmit GD, Atwell TD, Callstrom MR, Farrell MA, Leibovich BC, Patterson DE, Chow GK, Blute ML, Charboneau JW.
    J Endourol; 2010 Aug; 24(8):1255-62. PubMed ID: 20380510
    [Abstract] [Full Text] [Related]

  • 17. Percutaneous cryoablation of renal tumours: outcomes from 171 tumours in 147 patients.
    Breen DJ, Bryant TJ, Abbas A, Shepherd B, McGill N, Anderson JA, Lockyer RC, Hayes MC, George SL.
    BJU Int; 2013 Oct; 112(6):758-65. PubMed ID: 23581293
    [Abstract] [Full Text] [Related]

  • 18. Percutaneous radiofrequency thermal ablation of renal cell carcinoma: is it possible a day-hospital treatment?
    Carrafiello G, Laganà D, Ianniello A, Mangini M, Fontana F, Cotta E, Concollato L, Marconi A, Recaldini C, Dionigi G, Rovera F, Boni L, Cuffari S, Fugazzola C.
    Int J Surg; 2008 Oct; 6 Suppl 1():S31-5. PubMed ID: 19200792
    [Abstract] [Full Text] [Related]

  • 19. Percutaneous Cryoablation of Solitary, Sporadic Renal Cell Carcinoma: Outcome Analysis Based on Clear-Cell versus Papillary Subtypes.
    Haddad MM, Schmit GD, Kurup AN, Schmitz JJ, Boorjian SA, Geske J, Thompson RH, Callstrom MR, Atwell TD.
    J Vasc Interv Radiol; 2018 Aug; 29(8):1122-1126. PubMed ID: 29887184
    [Abstract] [Full Text] [Related]

  • 20. Percutaneous radiofrequency ablation of renal cell carcinomas in patients with solitary kidney: 6 years experience.
    Mylona S, Kokkinaki A, Pomoni M, Galani P, Ntai S, Thanos L.
    Eur J Radiol; 2009 Feb; 69(2):351-6. PubMed ID: 18313248
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 63.